AI MARKET SCANNING

Immatics NV

📅 Next Catalyst: Nov 17, 2026 (☀️ Open) 🏛️ NASDAQ 📁 Health Technology 🏭 Pharmaceuticals Major
AVG HISTORICAL GAP -0.40%
MAX GAP RECORD -12.45%
🔒 PRO INSTITUTIONAL AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡

SENTINEL HISTORICAL GAP VIEWER

// $IMTX
📊 1-YEAR TIMELINE (GAPS PLOTTED) 🔮 SIMULATE SETUP 🔒
Bullish Opening Gap Bearish Opening Gap T-1 Close Baseline

CATALYSTS & GAP HISTORY

Nov 17, 2026 Earnings Release 2026-11-17 (BEFORE OPEN (07:00)) 🔮 UPCOMING 🔒
Aug 18, 2026 Earnings Release 2026-08-18 (BEFORE OPEN)
-2.05%
May 12, 2026 Earnings Release 2026-05-12 (BEFORE OPEN)
-0.52%
Mar 05, 2026 Earnings Release 2026-03-05 (BEFORE OPEN)
+1.67%
Nov 17, 2025 Earnings Release 2025-11-17 (BEFORE OPEN)
+0.78%
Aug 13, 2025 Earnings Release 2025-08-13 (BEFORE OPEN)
-6.54%
May 13, 2025 Earnings Release 2025-05-13 (BEFORE OPEN)
-0.44%
Mar 27, 2025 Earnings Release 2025-03-27 (BEFORE OPEN)
+6.40%

VOLATILITY & GAP BIAS

AVG GAP MOVE 3.3%
Bullish Gaps (4)
Bearish Gaps (5)
Neutral / Flat (6)

QUANTITATIVE LIVE RADAR BLOTTER

Algorithmic execution stream for $IMTX

EXECUTIONS0 LOGS
STATUS🔒 ENCRYPTED
Execution Date Strategy & Setup Direction Execution Range Hold Time Net PnL
Radar monitoring: awaiting next setup.
🔒 Real-Time Strategy Telemetry Protected

Exact execution levels, Trailing Stops, and live bot signals are reserved for PRO members.

UNLOCK LIVE RADAR ⚡

📖 Intelligence Summary

Immatics NV is a clinical stage biopharmaceutical company, which engages in the research and development of T cell receptor-based immunotherapies for the treatment of cancer. Its pipeline includes adoptive cell therapy and TCR Bispecifics. The company was founded on March 10, 2020, and is headquartered in Tuebingen, Germany.

NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗